<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>239388</rcn>
  <id>101068419</id>
  <acronym>LIPIRNADO</acronym>
  <teaser>mRNA vaccines have gained considerable attentions in prevention and treatment of virus infections, cancer and genetic diseases, especially in the application to the COVID-19 pandemic in recent years. Due to the immunogenicity and instability of mRNA, the in vivo delivery of...</teaser>
  <objective>mRNA vaccines have gained considerable attentions in prevention and treatment of virus infections, cancer and genetic diseases, especially in the application to the COVID-19 pandemic in recent years. Due to the immunogenicity and instability of mRNA, the in vivo delivery of mRNA plays a crucial role in vaccine efficacy. Among various materials, lipid nanoparticles (LNPs) have shown to be one of the most potent carriers for mRNA delivery and successfully enter the clinic. To further improve vaccine efficacy, dendritic cells (DC) uptake can be optimized by decorating mannose ligands on LNP-mRNA formulations for targeted vaccine delivery. However, the effect of ligand density, spatial distance and organization pattern on cellular uptake remains poorly understood. Due to the addressability of DNA origami, nanoparticles and small molecules can be spatially organized into prescribed pattern with nanoscale precision. Therefore, we propose to develop designed ligand patten on LNP-mRNA formulations by transferring ligand pattern distributed on DNA origami to LNPs. With ligands modified on surface, LNP-mRNA formulations will be used to investigate the effect of ligand pattern on DC uptake, which is not accessible to other targeted delivery system. The results of the project will promote the development of vaccine delivery field. In addition, it will influence the health care and biomaterial industries, which are central to Europe’s ongoing and future economic success.</objective>
  <title>Targeted delivery of lipid nanoparticle-mRNA formulations modified with ligand pattern to dendritic cells based on DNA origami</title>
  <keywords>DNA origami, lipid nanoparticle, mRNA vaccine, drug delivery</keywords>
  <totalCost>0</totalCost>
  <ecMaxContribution>222727.68</ecMaxContribution>
  <startDate>2023-08-01</startDate>
  <endDate>2025-07-31</endDate>
  <ecSignatureDate>2022-06-09</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101068419</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-09-24 00:38:03</sourceUpdateDate>
  <contentCreationDate readOnly="true">2022-08-05 19:16:10</contentCreationDate>
  <contentUpdateDate>2025-10-22 11:55:45</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-10-22 11:57:06</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>55376</rcn>
        <title>HORIZON-MSCA-2021-PF-01</title>
        <identifier>HORIZON-MSCA-2021-PF-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55376</rcn>
        <title>HORIZON-MSCA-2021-PF-01</title>
        <identifier>HORIZON-MSCA-2021-PF-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="222727.68" terminated="false" sme="false" netEcContribution="222727.68" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1906240</rcn>
        <id>999978530</id>
        <vatNumber>SE202100297301</vatNumber>
        <legalName>KAROLINSKA INSTITUTET</legalName>
        <shortName>KAROLINSKA INSTITUTE</shortName>
        <address>
          <street>NOBELS VAG 5</street>
          <city>STOCKHOLM</city>
          <postalCode>171 77</postalCode>
          <country>SE</country>
          <postBox>N/A</postBox>
          <url>http://www.ki.se</url>
          <geolocation>59.3481714,18.0250493</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode readOnly="true">/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Stockholms län</name>
              <rcn>473436224</rcn>
              <nutsCode>SE110</nutsCode>
              <parents>
                <region>
                  <name>Stockholm</name>
                  <rcn>473436264</rcn>
                  <nutsCode>SE11</nutsCode>
                  <parents>
                    <region>
                      <name>Östra Sverige</name>
                      <rcn>473438760</rcn>
                      <nutsCode>SE1</nutsCode>
                      <parents>
                        <region>
                          <name>Sweden</name>
                          <rcn>473598504</rcn>
                          <nutsCode>SE</nutsCode>
                          <euCode>SE</euCode>
                          <isoCode>SE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Sweden</name>
              <rcn>473598504</rcn>
              <nutsCode>SE</nutsCode>
              <euCode>SE</euCode>
              <isoCode>SE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706003</rcn>
        <id>HORIZON_HORIZON-MSCA-2021-PF-01-01</id>
        <code>HORIZON-MSCA-2021-PF-01-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>MSCA Postdoctoral Fellowships 2021</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705729</rcn>
        <id>HORIZON.1.2</id>
        <code>HORIZON.1.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.2</pga>
        <title>Marie Skłodowska-Curie Actions (MSCA)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1128803</rcn>
        <id>101068419_1_DELIVHORIZON</id>
        <title>Data Management Plan</title>
        <description>The researcher fully supports open-access publishing as can be seen from the researcher’s recent publication record. Preprint articles will be also uploaded to open-access preprint repository like arXiv and BioRxiv. In addition, the research results will be presented at high-quality international conferences and workshops (such as FNANO, NANTECH, etc.). The data related to the published materials will be made available for example in Zenodo, in IDA Storage Service or in B2SHARE repositories under the Creative Commons license CC BY 4.0 to maximize the re-use of the data.All data will be stored on the group wiki page and institutional servers at KI and will be backed up by the University IT Services. If needed, cloud storages services will be used for storing nonconfidential data. Standardized protocols for the methods and treatments with clear instructions will be prepared, if not existing already, to ensure the repeatability. For quantitative data, sufficient repetitions will be made to ensure the consistency and quality. The folder structure will separate the different sample sets. The filenames will contain all descriptive and necessary information (the date at which the data was collected and, an abbreviation for the respective method or treatment applied, sample type) so that it will be easy to recognize them afterward. Datasets will be documented with the descriptive metadata (e.g., title, year of publication, dataset’s creator, description, keywords, etc.) which ensures understandability and findability of the data in the future. If needed, README files will be created for datasets to ascertain their re-usability, reading and interpretation.</description>
        <sourceUpdateDate>2024-07-09 08:47:57</sourceUpdateDate>
        <contentUpdateDate>2024-07-16 16:33:08</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode readOnly="true">/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/DMP</code>
              <title>Data Management Plan</title>
              <displayCode readOnly="true">/Data Management Plan</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webLink source="corda" type="projectDeliverable">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <defaultLanguage>en</defaultLanguage>
              <id>c9ad44ecd5a9c71208bc9bb0e3b9c176</id>
              <physUrl><![CDATA[https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e507c4bda3&appId=PPGMS]]></physUrl>
            </webLink>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1349896</rcn>
        <id>101068419_3_DELIVHORIZON</id>
        <title><![CDATA[Communication, Dissemination & Outreach Plan]]></title>
        <description>1. Dissemination of the project achievements to scientific communityThe expected scientific achievements in the project, including targeted delivery of LNP-mRNA vaccines and the effect of ligand patter on the immune cell uptake, will be published in peer-reviewed, and highly ranked journals, such as Nature nanotechnology, Nature Communications, Angewandte Chemie int. Ed., etc. Dr Sun will be the first author on the manuscripts that arise directly from her fellowship. Dr Sun will present scientific achievements at least on two highly regarded international conferences such as American Chemical Society (ACS) National Meeting and Material Research Society (MRS). In addition, Dr Sun will present her results in one of KI’s seminars, which are open to undergraduates, postgraduates and academic staff. Meanwhile, the scientific achievements will be displayed on KI’s website and Högber’s homepage to reach wider academic community.2. Communication measures and public engagement strategy of the actionThe researcher will produce a dedicated video clip on YouTube for the dissemination of targeted mRNA vaccine delivery technique as a beneficial outreach activity. The visual nature of the anticipated results lends itself very well for advertising the research to the public and the wider academic and commercial communities. Contact details on the webpage will encourage comments and discussions. The researcher will also participate in a European Researchers’ Night to communicate her results with a wider target audience. In addition, KI organises a number of open days where undergraduate courses and the research activities of the school are demonstrated to the public. The researcher will produce a poster and suitable video clips for these open days and be available to answer questions from the public. The researcher will also give a talk and prepare a video about the targeted vaccine delivery project idea and results.</description>
        <sourceUpdateDate>2025-08-25 08:12:51</sourceUpdateDate>
        <contentUpdateDate>2025-08-25 08:12:51</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode readOnly="true">/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/R</code>
              <title>Documents, reports</title>
              <displayCode readOnly="true">/Documents, reports</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webLink source="corda" type="projectDeliverable">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <defaultLanguage>en</defaultLanguage>
              <id>56bbd4eaa22e06e661aea7762f294869</id>
              <physUrl><![CDATA[https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e520e33001&appId=PPGMS]]></physUrl>
            </webLink>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/337/1015</code>
        <title>DNA</title>
        <displayCode readOnly="true">/natural sciences/biological sciences/genetics/DNA</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/137/133/9678651</code>
        <title>pandemics</title>
        <displayCode readOnly="true">/medical and health sciences/health sciences/public health/epidemiology/pandemics</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/25/69/435</code>
        <title>nano-materials</title>
        <displayCode readOnly="true">/engineering and technology/nanotechnology/nano-materials</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-TMA-MSCA-PF-EF</code>
        <title>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</title>
        <description>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</description>
        <displayCode readOnly="true">/HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
